GWA Study in Patients With Inflammatory Bowel Disease

Recruiting Observational Study
Crohn's Disease Ulcerative Colitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
3,600 (estimated)
Sponsor
Chinese University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim of this study is to identify new genes in Chinese patients that help investigators to understand the biological pathway and functions in a population in whom the incidence of Inflammatory Bowel Disease (IBD) is increasing. And to explore the genetic variations in Chinese patients with IBD.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 18 or above * Informed consent given by patient or family Case group (IBD patients) Diagnosis of Crohn's disease or ulcerative colitis defined by endoscopy, radiology and histology Control group (non-IBD cases) Ethically, sex and aged-matched controls attending clinics o…
Contacts

Siew C NG, PhD

+852 3505 3509

siewchienng@cuhk.edu.hk

CONTACT

Kim W AU, MSc

+852 3505 2640

kimau@surgery.cuhk.edu.hk

CONTACT